Drug Trial Radar · NCT07675226
Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions
Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Jul 10, 2026
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Oscotec Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 30, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is an open-label, randomized, crossover Phase 1 study to evaluate the bioequivalence, pharmacokinetics, and safety of two oral SKI-O-703 drugs (test and reference) in healthy adults under fed conditions. Approximately 48 Korean and Caucasian participants will receive a single oral dose of the test drug and a single oral dose of the reference drug in a randomized sequence, separated by a washout period, with pharmacokinetic sampling and safety assessments performed throughout the study.
Conditions
- Bioequivalence Study in Healthy Subjects
- Immune Thrombocytopenia (ITP)
- Rheumatoid Arthritis (RA)
Interventions
SKI-O-703 API in CapsulesDrug
SKI-O-703 API in Capsules 100mg
SKI-O-703 Formulated Granules in CapsulesDrug
SKI-O-703 Formulated Granules in Capsules 200mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- To measure AUCt of SKI-O-592 (the free base of SKI-O-703)Time frame: Approximately 1 year
- To measure Cmax of SKI-O-592 (the free base of SKI-O-703)Time frame: Approximately 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Oscotec
Seongnam-si, Gyeonggi-do, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.